Open Access

Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats

  • Authors:
    • Huanjin Cui
    • Jiayu He
    • Hongwu Chen
    • Jinwen Chen
    • Xinhua Qian
    • Weimin Huang
  • View Affiliations

  • Published online on: November 29, 2016     https://doi.org/10.3892/br.2016.820
  • Pages: 32-38
  • Copyright: © Cui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to observe the effects of recombinant human erythropoietin (rhEPO) on the expression of epidermal growth factor‑like domain 7 (EGFL7) and cell apoptosis in lung tissue following hyperoxic lung injury in newborn rats. The 96 Sprague-Dawley newborn rats were randomly divided into 4 groups (n=24) as follows: Room air‑exposed control group, room air-exposed rhEPO-treated group, hyperoxia‑exposed group and the hyperoxia-exposed rhEPO-treated group. Pups (n=8) from each group were sacrificed on postnatal days 3, 7 and 14. The pulmonary morphometric and microvessel density changes were observed. In addition, the mRNA and protein expression levels of EGFL7, B-cell lymphoma 2 (Bcl-2) and Bcl-2-like protein 4 (Bax) in lung tissue samples were measured. The rats in the hyperoxia-exposed group exhibited alveolar and pulmonary vascular dysplasia, as well as low mRNA and protein expression levels of EGFL7 and Bcl‑2, in addition to high level of Bax in the lung tissue samples when compared with the room air‑exposed control group (P<0.05). However, in the hyperoxia‑exposed rhEPO‑treated group the lung histopathology was improved, and the protein and mRNA expression levels of EGFL7 and Bcl‑2 were increased compared with the hyperoxia‑exposed group (P<0.05). Furthermore, the expression level of Bax was lower than that of the hyperoxia‑exposed group (P<0.05). The present study demonstrated that rhEPO promotes alveolar development and increases pulmonary vascular density by upregulating the expression level of EGFL7 in hyperoxia‑induced lung injury of newborn rats.
View Figures
View References

Related Articles

Journal Cover

January-2017
Volume 6 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cui H, He J, Chen H, Chen J, Qian X and Huang W: Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats. Biomed Rep 6: 32-38, 2017.
APA
Cui, H., He, J., Chen, H., Chen, J., Qian, X., & Huang, W. (2017). Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats. Biomedical Reports, 6, 32-38. https://doi.org/10.3892/br.2016.820
MLA
Cui, H., He, J., Chen, H., Chen, J., Qian, X., Huang, W."Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats". Biomedical Reports 6.1 (2017): 32-38.
Chicago
Cui, H., He, J., Chen, H., Chen, J., Qian, X., Huang, W."Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats". Biomedical Reports 6, no. 1 (2017): 32-38. https://doi.org/10.3892/br.2016.820